Rexilo Pharma Private Limited

Rexilo Pharma Private Limited - trading in Howrah, West Bengal, India. Directors, charges & compliance details.
CIN U51909WB2021PTC250044 Incorporated 02 December 2021 ROC Kolkata HQ Howrah, West Bengal, India
Active Private Limited Company trading MSME · Micro
Revenue · FY 2023
₹16.74 Lakh
Latest filing
Net loss · FY 2023
₹13,178
Net margin -0.8%
EBITDA · FY 2023
₹68,077
EBITDA margin 4.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date

About Rexilo Pharma Private Limited

Data last updated:

Rexilo Pharma Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 December 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2021PTC250044.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sk Sanu and Sk Abul Basar.

Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401.

As per the financials filed for FY 2023, the company reported a revenue of ₹16.74 Lakh. For the same year it recorded a net loss of ₹13,178 (net margin -0.8%) and EBITDA of ₹68,077 (EBITDA margin 4.1%).

Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

Rexilo Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0018496).

Company details

CIN U51909WB2021PTC250044
Registration Number 250044
Incorporation Date 02 December 2021
ROC Kolkata
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-WB-08-0018496

Recognitions & Rankings of Rexilo Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-WB-08-0018496

Contact details

Rexilo Pharma Private Limited's registered office is in Howrah, West Bengal.

  • Registered Address
    C/O Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Rexilo Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rexilo Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rexilo Pharma Private Limited, buy the company report.

Financials of Rexilo Pharma Private Limited

FY 2023 filings available

Rexilo Pharma Private Limited reported revenue of ₹16.74 Lakh for FY 2023.

Revenue · FY 2023
₹16.74 Lakh
Net loss · FY 2023
₹13,178 margin -0.8%
EBITDA · FY 2023
₹68,077 margin 4.1%

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹68,077
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13,178
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin4.1%
Net Profit Margin-0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rexilo Pharma Private Limited, buy the company report.

Board of directors of Rexilo Pharma Private Limited

Rexilo Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sk SanuDirector02 Dec 20214 Years 11 MonthsCurrent
Sk Abul BasarDirector02 Dec 20214 Years 11 MonthsCurrent

Peer comparison

Rexilo Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
A B R Drugs Private Limited₹16.75 Lakh (FY 2024)9.0%New Delhi, Delhi, India
Febo Tradeguru Private Limited₹16.75 Lakh (FY 2023)Kolkata, West Bengal, India
Eastpoint Seeds Private Limited₹16.75 Lakh (FY 2023)Bangalorerural, Karnataka, India
Dev Bhoomi Recycling Private Limited₹16.75 Lakh (FY 2024)-79.0%Dehradun, Uttarakhand, India
Wemron Trading (OPC) Private Limited₹16.75 Lakh (FY 2022)0.0%Patna, Bihar, India
Rexilo Pharma Private Limitedthis company₹16.74 Lakh (FY 2023)-₹13,178-0.8%Howrah, West Bengal, India
Excellent Exim & Commerce Pvt. Ltd.₹16.74 Lakh (FY 2024)10756.0%Kolkata, West Bengal, India
Vedansh Hi-Tech Engineers Private Limited₹16.74 Lakh (FY 2022)345.0%Nagpur, Maharashtra, India
Caegis Pharma (OPC) Private Limited₹16.74 Lakh (FY 2024)-28.0%New Delhi, Delhi, India
Pureorganics and Foods India Private Limited₹16.73 Lakh (FY 2025)43.0%New Delhi, Delhi, India
Shulyn Realty Private Limited₹16.73 Lakh (FY 2024)Gautam Budh Nagar, Uttar Pradesh, India

To see the full peer comparison of Rexilo Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rexilo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Rexilo Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Rexilo Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sk Abul Basar was appointed as Director on 02 Dec 2021.

AGM
Rexilo Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
Filing
Rexilo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata Ii.
Appointed
Sk Abul Basar was appointed as Director.
Appointed
Sk Sanu was appointed as Director.
Incorporation
02 Dec 2021
Rexilo Pharma Private Limited was registered on 02 Dec 2021 with Roc Kolkata Ii & aged 4 years 11 months as per MCA records.

Frequently asked questions

Rexilo Pharma is an active private limited company based in Howrah, West Bengal, India. The company works in specialty, within the trading industry. It was incorporated on 02 December 2021 (5+ years old) and is registered under CIN U51909WB2021PTC250044.

Rexilo Pharma has 2 current directors:

The latest financial statements of Rexilo Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Rexilo Pharma is U51909WB2021PTC250044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rexilo Pharma has 1 court case on record: 1 filed against it. 1 is pending.

Rexilo Pharma was incorporated on 02 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Rexilo Pharma by revenue are A B R Drugs Private Limited, Febo Tradeguru Private Limited, Eastpoint Seeds Private Limited, Dev Bhoomi Recycling Private Limited, Wemron Trading (OPC) Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Sk Abul Basar was appointed as Director on 02 Dec 2021. Sk Sanu was appointed as Director on 02 Dec 2021.

Yes, Rexilo Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0018496).

The registered office of Rexilo Pharma is at CO Sk Abul Basar Vill & P.O – Jaypur P.S – Jaypur Amta – 2 Dist – Howrah, West Bengal, India – 711401.

Rexilo Pharma operates in the trading industry, in the specialty segment.